Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in subjects with T2DM inadequately controlled with diet and exercise.In this 26-week, randomized, double-blind, placebo-controlled,...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
2012
|
| Online Access: | https://doi.org/10.1111/dom.12054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|